10.1016/j.tem.2011.10.005 Trends Endocrinol
In this study, we used nationwide registers in Sweden to assess treatment discontinuation, reinitiation and switching for GLP-1 receptor agonists and SGLT2 inhibitors in patients with type 2 diabetes
Contact our office immediately if you experience this symptom
Popular weight-loss drugs Ozempic and Wegovy may slow biological aging By calming inflammation and reducing excess fat, semaglutide may postpone several molecular signs of aging, pointing to the potential of GLP1 receptor agonists to help prevent agerelated diseases Date: July 14, 2026 Source: University of California - San Diego Summary: Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging
I think thats just part of the inherent bias towards the treatment of people with obesity, feeling like its cheating or not necessary